Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Herbal medicines and nonalcoholic fatty liver disease
Hong Yao, Yujie Qiao, Zhao Ya-li, et al.
World Journal of Gastroenterology (2016) Vol. 22, Iss. 30, pp. 6890-6890
Open Access | Times Cited: 127

Showing 1-25 of 127 citing articles:

Epidemiological Features of NAFLD From 1999 to 2018 in China
Jianghua Zhou, Feng Zhou, Wenxin Wang, et al.
Hepatology (2020) Vol. 71, Iss. 5, pp. 1851-1864
Closed Access | Times Cited: 520
Natural products for the treatment of type 2 diabetes mellitus: Pharmacology and mechanisms
Lina Xu, Yue Li, Yan Dai, et al.
Pharmacological Research (2018) Vol. 130, pp. 451-465
Closed Access | Times Cited: 374
Flavonoids and type 2 diabetes: Evidence of efficacy in clinical and animal studies and delivery strategies to enhance their therapeutic efficacy
Tarique Hussain, Bie Tan, Ghulam Murtaza, et al.
Pharmacological Research (2020) Vol. 152, pp. 104629-104629
Open Access | Times Cited: 160
CYP2E1 in Alcoholic and Non-Alcoholic Liver Injury. Roles of ROS, Reactive Intermediates and Lipid Overload
Riina Harjumäki, Chris S. Pridgeon, Magnus Ingelman‐Sundberg
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8221-8221
Open Access | Times Cited: 141
New insights into the role of mitochondrial dynamics in oxidative stress-induced diseases
Sisi Chen, Qilong Li, Hanjing Shi, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117084-117084
Open Access | Times Cited: 33
Herbal Medicine in the Treatment of Non-Alcoholic Fatty Liver Diseases-Efficacy, Action Mechanism, and Clinical Application
Yu Xu, Wei Guo, Cheng Zhang, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 111
Ginsenoside Rb2 Alleviates Hepatic Lipid Accumulation by Restoring Autophagy via Induction of Sirt1 and Activation of AMPK
Qi Huang, Ting Wang, Liu Yang, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 5, pp. 1063-1063
Open Access | Times Cited: 102
Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver Disease
Manuel Suárez, Noemí Boqué, Josep M Del Bas-Prior, et al.
Nutrients (2017) Vol. 9, Iss. 10, pp. 1052-1052
Open Access | Times Cited: 89
Chinese herbal medicines: The modulator of nonalcoholic fatty liver disease targeting oxidative stress
Pin Gong, Hui Long, Yuxi Guo, et al.
Journal of Ethnopharmacology (2023) Vol. 318, pp. 116927-116927
Closed Access | Times Cited: 30
Antioxidant activities of ginsenoside Rg1 against cisplatin-induced hepatic injury through Nrf2 signaling pathway in mice
Yan Gao, Shifeng Chu, Qian-hang Shao, et al.
Free Radical Research (2016) Vol. 51, Iss. 1, pp. 1-13
Closed Access | Times Cited: 79
Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis
Daniel Cabrera, Alexander Wree, Davide Povero, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 78
Dual Specificity Phosphatase 12 Regulates Hepatic Lipid Metabolism Through Inhibition of the Lipogenesis and Apoptosis Signal–Regulating Kinase 1 Pathways
Zhen Huang, Leiming Wu, Jielei Zhang, et al.
Hepatology (2019) Vol. 70, Iss. 4, pp. 1099-1118
Open Access | Times Cited: 60
Chromophore‐Modified Highly Selective Ratiometric Upconversion Nanoprobes for Detection of ONOO−‐Related Hepatotoxicity In Vivo
Xiao Liu, Huanhua Lai, Juanjuan Peng, et al.
Small (2019) Vol. 15, Iss. 43
Closed Access | Times Cited: 58
New insight and potential therapy for NAFLD: CYP2E1 and flavonoids
Kaiyue Wang, Wangxiao Tan, Xiao Liu, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111326-111326
Open Access | Times Cited: 48
Berbamine induced activation of the SIRT1/LKB1/AMPK signaling axis attenuates the development of hepatic steatosis in high-fat diet-induced NAFLD rats
Ankita Sharma, Sumit Kr Anand, Neha Singh, et al.
Food & Function (2021) Vol. 12, Iss. 2, pp. 892-909
Closed Access | Times Cited: 45
Walnuts ameliorated hepatic inflammation and toxicity induced by thermally oxidised high-fat diet in mice
Gauhar Ali, Alam Zeb
Journal of Functional Foods (2024) Vol. 114, pp. 106080-106080
Open Access | Times Cited: 7
Polydopamine nanoparticles as a non-pharmaceutical tool in the treatment of fatty liver disease
Alessio Carmignani, Matteo Battaglini, Martina Bartolucci, et al.
Materials & Design (2024) Vol. 239, pp. 112825-112825
Open Access | Times Cited: 5
Herbal medicine as a potential treatment for non-alcoholic fatty liver disease
Wenyi Nie, Ye Yang, Hongxuan Tong, et al.
World Journal of Gastroenterology (2025) Vol. 31, Iss. 9
Closed Access
Chinese Herbal Medicines Attenuate Acute Pancreatitis: Pharmacological Activities and Mechanisms
Hong Xiang, Qingkai Zhang, Bing Qi, et al.
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 55
The Impacts of Herbal Medicines and Natural Products on Regulating the Hepatic Lipid Metabolism
Sha Li, Yu Xu, Wei Guo, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 49
Neglected features of lifestyle: Their relevance in non-alcoholic fatty liver disease
Francesca M. Trovato, Giuseppe Fabio Martines, Daniela Brischetto, et al.
World Journal of Hepatology (2016) Vol. 8, Iss. 33, pp. 1459-1459
Open Access | Times Cited: 48
Tannic acid, a novel histone acetyltransferase inhibitor, prevents non-alcoholic fatty liver disease both in vivo and in vitro model
Min‐Yu Chung, Ji‐Hye Song, Jinhyuk Lee, et al.
Molecular Metabolism (2018) Vol. 19, pp. 34-48
Open Access | Times Cited: 46
Phloretin ameliorates hepatic steatosis through regulation of lipogenesis and Sirt1/AMPK signaling in obese mice
Chian‐Jiun Liou, Shu-Ju Wu, Szu‐Chuan Shen, et al.
Cell & Bioscience (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 41
Effects of Poria cocos extract on metabolic dysfunction-associated fatty liver disease via the FXR/PPARα-SREBPs pathway
Jinbiao He, Yu Yang, Fan Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 26
Pelargonidin-3-O-Glucoside Encapsulated Pectin-Chitosan-Nanoliposomes Recovers Palmitic Acid-Induced Hepatocytes Injury
Naymul Karim, Mohammad Rezaul Islam Shishir, Yuting Li, et al.
Antioxidants (2022) Vol. 11, Iss. 4, pp. 623-623
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top